Filter News
Area of Research
News Topics
- (-) Biomedical (29)
- (-) Net Zero (8)
- 3-D Printing/Advanced Manufacturing (42)
- Advanced Reactors (8)
- Artificial Intelligence (48)
- Big Data (27)
- Bioenergy (51)
- Biology (60)
- Biotechnology (12)
- Buildings (20)
- Chemical Sciences (26)
- Clean Water (14)
- Climate Change (50)
- Composites (8)
- Computer Science (87)
- Coronavirus (17)
- Critical Materials (4)
- Cybersecurity (14)
- Decarbonization (46)
- Education (1)
- Emergency (2)
- Energy Storage (29)
- Environment (104)
- Exascale Computing (27)
- Fossil Energy (4)
- Frontier (25)
- Fusion (31)
- Grid (25)
- High-Performance Computing (45)
- Hydropower (5)
- Isotopes (27)
- ITER (2)
- Machine Learning (22)
- Materials (43)
- Materials Science (46)
- Mathematics (7)
- Mercury (7)
- Microelectronics (2)
- Microscopy (20)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (39)
- Neutron Science (47)
- Nuclear Energy (55)
- Partnerships (19)
- Physics (30)
- Polymers (8)
- Quantum Computing (21)
- Quantum Science (30)
- Renewable Energy (1)
- Security (11)
- Simulation (32)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (31)
- Sustainable Energy (47)
- Transformational Challenge Reactor (3)
- Transportation (27)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
Ada Sedova’s journey to Oak Ridge National Laboratory has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.